BioNexus Gene Lab Corp — Balance Sheet (NASDAQ:BGLC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 10.12 M9.57 M8.74 M11.4 M10.43 M9.25 M Total liabilities 3.45 M2.39 M2.08 M1.74 M2.11 M637.86 K Total equity 6.66 M7.18 M6.67 M9.66 M8.32 M8.61 M Total liabilities & shareholders' equities 10.12 M9.57 M8.74 M11.4 M10.43 M9.25 M Total debt —————— Net debt ——————

News

BioNexus Gene Lab appoints commercial officer at Fidelion

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics

BioNexus Gene Lab stock falls after securing $500M equity facility

BioNexus Gene Lab secures $500 million equity purchase agreement

BioNexus Gene Lab stock climbs after securing $500 million equity facility

BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform

BioNexus Gene Lab stock soars after strategic MRD testing agreements

BioNexus Gene Lab files $100 million shelf registration, launches ATM program

BioNexus Gene Lab enters strategic partnership talks with BirchBioMed

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.38%

US Stocks Edge Higher; Kraft Heinz Earnings Top Views - BioNexus Gene Lab (NASDAQ:BGLC), Kraft Heinz (NASDAQ:KHC)

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - BioNexus Gene Lab (NASDAQ:BGLC), 180 Life Sciences (NASDAQ:ATNF)